Microsoft Forecast, price target & analysts
Microsoft Target price 2026 - Analyst rating & recommendation
Microsoft Classifications & Recommendation
Microsoft Price Target
| Target Price | $612.00 |
| Price | $532.60 |
| Potential | 14.91% |
| Number of Estimates | 62 |
| 62 Analysts have issued a price target Microsoft 2027 . The average Microsoft target price is $612.00. This is 14.91% higher than the current stock price. The highest price target is $913.50 71.52% , the lowest is $404.00 24.15% . | |
| A rating was issued by 69 analysts: 64 Analysts recommend Microsoft to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Microsoft stock has an average upside potential 2027 of 14.91% . Most analysts recommend the Microsoft stock at Purchase. |
Sales and Margin forecast 2027, 2028 to 2033
63 Analysts have issued a sales forecast Microsoft 2027 . The average Microsoft sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
35 Analysts have issued an Microsoft EBITDA forecast 2027. The average Microsoft EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
63 Microsoft Analysts have issued a net profit forecast 2027. The average Microsoft net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033
Current Microsoft Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Guggenheim |
Buy
➜
Buy
|
Unchanged | Oct 21 2026 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 20 2026 |
| Bernstein |
Outperform
➜
Outperform
|
Unchanged | Oct 19 2026 |
| StoneX |
Buy
➜
Buy
|
Unchanged | Oct 16 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 15 2026 |
| Mizuho |
Outperform
➜
Outperform
|
Unchanged | Oct 15 2026 |
| Jefferies |
Buy
➜
Buy
|
Unchanged | Oct 15 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Guggenheim:
Buy
➜
Buy
|
Oct 21 2026 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Oct 20 2026 |
|
Unchanged
Bernstein:
Outperform
➜
Outperform
|
Oct 19 2026 |
|
Unchanged
StoneX:
Buy
➜
Buy
|
Oct 16 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 15 2026 |
|
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Oct 15 2026 |
|
Unchanged
Jefferies:
Buy
➜
Buy
|
Oct 15 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
